ICYMI: AFP-AR Presents Believe in Arkansas Awards to A+ Legislators
Dec 21, 2023

Little Rock, AR—Earlier this fall, Americans for Prosperity-AR (AFP-AR) released its annual scorecard, featuring 100 perfectly rated legislators who have supported policies that promote a free society. AFP-AR presented the perfectly rated leaders with “Believe in Arkansas” plaque awards to thank them for working on economic progress, foundational education, and improving healthcare in Arkansas. Notably, State Senator Breanne Davis was among legislators who received the Believe in […]

Read More
Why government confiscation of drug patents is the wrong way to increase competition and reduce prices
Dec 18, 2023

UPDATE (February 5, 2024): AFP submitted a letter to the federal register urging the administration to withdraw its proposal. Click here to read the full letter. Last week, the Biden administration announced a plan to give itself a new power to confiscate pharmaceutical drug patents whenever federal officials deem a prescription drug “too expensive.” Under […]

Read More
AFP-Kansas Releases Response to Governor Kelly’s Plans to Expand Medicaid
Dec 14, 2023

Wichita, KS—The fact remains that expanding Medicaid impedes care options to the most vulnerable in our society—making it harder for rural care providers and those in need from receiving the help they require. That’s why Kansas was among the ten states who opposed expanding the program. However, Governor Laura Kelly is doubling down on this […]

Read More
Americans for Prosperity Press Release
AFP Applauds House for Passing the Bipartisan Lower Costs, More Transparency Act
Dec 11, 2023

Legislation chips away at unfair billing in Medicare by including site neutral payments for drug administration services at outpatient facilities.

Read More
A screen shot from AFP's ad calling on Congress to end unfair billing by making Medicare payments site neutral.
New Ad Urges Congress to End Unfair Billing in Medicare
Nov 29, 2023

Ad part of AFP’s new six-figure push to pass legislation that would enact site neutral payment policies in Medicare. Arlington, Va. – Today, Americans for Prosperity announced the release of a new ad urging lawmakers on Capitol Hill to end unfair billing in Medicare by enacting site neutral payment reform. “Why does Medicare pay hospital […]

Read More
Americans for Prosperity – Georgia Issues Statement Applauding Senate Study Committee Certificate of Need Recommendations
Nov 28, 2023

ATLANTA, GA – Today, following the announcement from the Senate Study Committee on Certificate of Need Reform recommending a full repeal of Georgia’s Certificate of Need (CON) laws, Americans for Prosperity – Georgia (AFP-GA) is applauding the decision and calling on lawmakers to follow the Committee’s recommendations in the upcoming legislative session. AFP-GA State Director […]

Read More
AFP-GA to House Study Committee on Certificate of Need Reform: “Stay Focused on CON”
Nov 16, 2023

Committee Hearing Today on Medicaid Expansion Distracts Committee from its True Task  Atlanta, Georgia—Today the Georgia House Study Committee on Certificate of Need (CON) Reform heard testimony from out-of-state experts on Medicaid Expansion. Witnesses from Arkansas testified before the CON Study Committee about the supposed benefits of expanding Medicaid in the Peach State.  Americans for […]

Read More
Americans for Prosperity Press Release
Real Clear Health: Health Care Open Enrollment Is a Headache for Many, but It Doesn’t Have to Be
Nov 7, 2023

In an op-ed published at Real Clear Health, Lauren Stewart, senior legislative affairs liaison for Americans for Prosperity and Concerned Veterans for America, revealed the many health care options that Americans are missing out on due to misguided government policies. With open enrollment for 2024 health insurance coverage underway, Stewart explained that, for many Americans, […]

Read More
Bipartisan legislation would accelerate FDA drug approval process
Nov 7, 2023

On average, it takes a decade and hundreds of millions of dollars to get a new drug or medication approved by the U.S. Food and Drug Administration (FDA).

Read More